RankingsPricing
  1. US-listed companies
  2. VERTEX PHARMACEUTICALS INC
  3. Financials
  4. Operating expenses

VERTEX PHARMACEUTICALS INCVRTX

Market cap
$109.6B
P/E ratio
SummaryFinancials
Period EndOperating expenses (Million USD)YoY (%)
Dec 31, 202411,253+86.39%
Dec 31, 20236,037+30.58%
Dec 31, 20224,623-3.53%
Dec 31, 20214,792+43.08%
Dec 31, 20203,349+12.95%
Dec 31, 20192,965+22.91%
Dec 31, 20182,412+1.99%
Dec 31, 20172,365+39.78%
Dec 31, 20161,692+12.88%
Dec 31, 20151,499+17.79%
Dec 31, 20141,273-39.83%
Dec 31, 20132,115+38.74%
Dec 31, 20121,525+17.57%
Dec 31, 20111,297+54.48%
Dec 31, 2010839

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating income Operating expenses Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSAdjusted EPSDividend payout ratio (%)Dividend per shareAdjusted DPSEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)